Home › Trial NCT06462794
First In Human Study of CX-801 in Advanced Solid Tumors
- Trial IDNCT06462794
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorCytomX Therapeutics
- Enrollment121
- Start date2024-08-28
- ConditionsSolid Tumor, Adult
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.